Passage Bio Inc.

NASDAQ: PASG · Real-Time Price · USD
6.89
-0.70 (-9.22%)
At close: Aug 15, 2025, 3:59 PM
7.10
2.97%
After-hours: Aug 15, 2025, 04:10 PM EDT

Passage Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.21M 3.21M 3.21M 5.91M 5.91M 5.91M 5.91M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.92M 2.52M 3.13M 3.21M 3.41M 3.59M 3.76M 3.9M 3.83M 3.77M 3.68M 3.4M 2.93M 2.21M 1.54M 874K 414K 211K
Gross Profit
405K -195K -800K 2.7M 2.5M 2.32M 2.15M -3.9M -3.83M -3.77M -3.68M -3.4M -2.93M -2.21M -1.54M -874K -414K -211K
Operating Income
-61.77M -68.81M -70.4M -74.58M -82.55M -90.56M -108.39M -118.19M -117.04M -131.47M -138.39M -161.31M -180.88M -189.61M -185.73M -173.63M -155.15M -133.92M
Interest Income
2.6M 3.8M 4.4M 5.1M 4M 2.8M 1.5M 1.17M 2M 2.27M 2.27M 1.1M 463K 292K 343K 449K 362K 395K
Pretax Income
-56.85M -63.46M -64.77M -68.8M -76.57M -84.44M -102.06M -112.38M -111.97M -127.65M -136.13M -160.21M -180.42M -189.31M -185.39M -173.18M -154.79M -133.53M
Net Income
-56.85M -63.46M -64.77M -68.8M -76.57M -84.44M -100.52M -109.66M -109.25M -124.66M -134.68M -159.94M -180.15M -189.31M -185.39M -173.18M -154.79M -133.53M
Selling & General & Admin
22.57M 24.56M 24.99M 25.75M 26.69M 28.24M 40.77M 45.88M 48.36M 53.29M 49.34M 55.95M 60.26M 62.69M 60.06M 52.99M 45.8M 37.78M
Research & Development
31.77M 36.38M 40.18M 42.78M 49.22M 56.12M 61.42M 66.92M 67.18M 76.68M 86.05M 101.36M 112.63M 118.92M 117.67M 112.64M 106.85M 93.64M
Other Expenses
5.4M 5.84M 6.04M 6.04M 6.63M 7.73M 9.27M 8.47M 3.9M 2.64M 1.1M 1.1M 271K 1K n/a n/a n/a n/a
Operating Expenses
59.73M 66.78M 71.21M 74.58M 82.55M 90.56M 108.39M 118.19M 115.54M 129.97M 135.39M 157.31M 172.88M 181.61M 177.73M 165.63M 152.65M 131.42M
Interest Expense
n/a n/a n/a 1.54M 1.54M 1.54M 1.54M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a -807K -807K -807K -807K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
59.13M 66.17M 70.4M 74.58M 82.55M 90.56M 108.39M 118.19M 117.04M 131.47M 136.89M 158.81M 172.88M 181.61M 177.73M 165.63M 152.65M 131.42M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -1.54M -2.72M -2.72M -2.99M -1.44M -277K -463K -292K -291K -397K -310K -343K
Shares Outstanding (Basic)
3.17M 3.11M 3.1M 3.09M 3.08M 2.81M 2.75M 2.74M 2.73M 2.73M 2.73M 2.72M 2.72M 2.71M 2.7M 2.7M 2.69M 2.57M
Shares Outstanding (Diluted)
3.17M 3.11M 3.1M 3.09M 3.08M 2.81M 2.75M 2.74M 2.73M 2.73M 2.73M 2.72M 2.72M 2.71M 2.7M 2.7M 2.69M 2.57M
EPS (Basic)
-18.28 -20.5 -21.48 -23.48 -27.12 -30.74 -36.8 -40.1 -40 -45.6 -49.4 -59 -66.6 -70.2 -69.6 -67.6 -62.8 -56.8
EPS (Diluted)
-18.28 -20.5 -21.48 -23.48 -27.12 -30.74 -36.8 -40.1 -40 -45.6 -49.4 -59 -66.6 -70.2 -69.6 -67.6 -62.8 -56.8
EBITDA
-52.65M -58.46M -62.09M -66.17M -73.35M -81.62M -99.28M -108.94M -111.71M -126.19M -131.72M -153.91M -169.95M -179.39M -176.19M -164.47M -151.69M -130.46M
EBIT
-53.38M -60.94M -65.17M -69.34M -80.55M -88.99M -105.28M -113.91M -112.82M -127.25M -134.22M -157.31M -172.88M -181.61M -177.73M -165.63M -152.65M -131.42M
Depreciation & Amortization
1.88M 2.48M 3.08M 3.17M 3.37M 3.55M 3.72M 3.86M 3.83M 3.77M 3.68M 3.4M 2.93M 2.21M 1.54M 1.15M 967K 962K